ArticleFrontiers in oncology2026
Identifying key risk factors for thrombocytopenia in patients undergoing radical chemoradiotherapy for nasopharyngeal cancer: a retrospective study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In this study, we investigated the risk factors for thrombocytopenia in patients undergoing radical chemoradiotherapy for nasopharyngeal carcinoma (NPC). Methods: We retrospectively analyzed clinical data and laboratory indicators of 318 patients initially diagnosed with NPC who received radical chemoradiotherapy at our institution between January 2013 and May 2024. The patients were stratified into three groups based on the severity of post-chemoradiotherapy thrombocytopenia. Clinical parameters and laboratory indices were then systematically compared among these groups. Results: Platelet counts before and after chemoradiotherapy differed significantly (Z = -15.421; Conclusion: Smoking and low baseline platelet counts were independent risk factors for thrombocytopenia following radical chemoradiotherapy in patients with NPC. Therefore, dynamic monitoring of platelet levels in smokers and in those with low preoperative counts is crucial throughout treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.